Evidence map›Paper›PMID 22059171›Full record

ReviewCanadian journal of gastroenterology = Journal canadien de gastroenterologie2011

Endoscopic treatment of obesity.

Agnieszka Swidnicka-Siergiejko, Eugeniusz Wróblewski, Dabrowski Andrzej

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05420506 (Treatment of Obesity Without Surgical Intervention by Reversible Reduction of the Small Intestinal Absorption Area), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05420506 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Treatment of Obesity Without Surgical Intervention by Reversible Reduction of the Small Intestinal Absorption Area

TypeinterventionalSponsorYeditepe UniversityRan2022 to 2024Enrolled20ConditionsMorbid ObesityArmsNROT1
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Intra-gastric balloons - The past, present and future.Annals of medicine and surgery (2012) · 2021
    Review
  4. Gastric Botulinum Toxin-A Application for Weight Loss Therapy.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2018
    Review
  9. Review
  10. Review
  11. Role of endoscopy in the bariatric surgery of patients.World journal of gastroenterology · 2014
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Agnieszka Swidnicka-SiergiejkoDepartment of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland. agnkatswidnicka@op.pl
Eugeniusz Wróblewski
Dabrowski Andrzej
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe increasing incidence of obesity and overweight among children and adolescents will be reflected by the imminent increase in the number of obese patients who require more definitive methods of treatment. There is great interest in new, safe, simple, nonsurgical procedures for weight loss.

objectiveTo provide an overview of new endoscopic methods for the treatment of obesity.

methodsAn English-language literature search on endoscopic interventions, endoscopically placed devices and patient safety was performed in the MEDLINE and Cochrane Library databases.

resultsThe literature search yielded the following weight loss methods: space-occupying devices (widely used), gastric capacity reduction, modifying gastric motor function and malabsorptive procedures. A commercially available intragastric balloon was the most commonly used device for weight loss. In specific subgroups of patients, it improved quality of life, decreased comorbidities and served as a bridge to surgery. More evidence regarding the potential benefits and safety of other commercially available intragastric balloons is needed to clarify whether they are superior to the most commonly used one. Moreover, early experiences with transoral gastroplasty, the duodenal-jejunal bypass sleeve and an adjustable, totally implantable intragastric prosthesis, indicate that they may be viable options for obesity treatment. Other agents, such as botulinum toxin and a device known as the 'butterfly', are currently at the experimental stage.

conclusionNew endoscopic methods for weight loss may be valuable in the treatment of obesity; however, more clinical experience and technical improvements are necessary before implementing their widespread use.

Indexed as

BariatricsEndoscopy, GastrointestinalGastric BalloonGastroplastyHumansJejunoileal BypassObesityPatient SafetyQuality of LifeStomachTherapies, InvestigationalTreatment OutcomeWeight Loss

Identifiers

PMID22059171
PMCPMC3222773
OpenAlexW21217881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.